• 1
    Lahiff C, Safaie P, Awais A, et al. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2013; 37: 78694.
  • 2
    Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2006; 107: 147482.
  • 3
    Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 51230.
  • 4
    Thia K, Faubion WA Jr, Loftus EV Jr, et al. Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index. Inflamm Bowel Dis 2011; 17: 10511.
  • 5
    Quigley EMM, Shanahan F. Irritable bowel syndrome and inflammatory bowel disease: is there an overlap? Pract Gastroenterol 2010; 34: 327.
  • 6
    Quigley EMM, Bernstein CN. “Irritable bowel symptoms” in inflammatory bowel disease: diagnostic uncertainty meets pathological reality. Am J Gastroenterol 2012; 107: 14835.
  • 7
    Keohane J, O'Mahony C, O'Mahony L, et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010; 105: 178994.